IMMUNOPRECISE ANTIBODIES LTD (IPA)
CA45257F2008 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.364M 8.11% | 20.665M 6.72% | 24.518M 18.65% | 24.978M 1.88% | 27.451M 9.90% | 37.187M 35.47% | 52.762M 41.88% | 63.696M 20.72% | 77.048M 20.96% | 93.412M 21.24% | |
| EBITDA YoY % growth | -12.474M -289.08% | -21.866M -75.29% | -8.358M 61.78% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -16.243M -134.76% | -28.551M -75.77% | -14.093M 50.64% | -12.683M 10.00% | -5.519M 56.49% | 1.513M 127.42% | 5.795M 283.01% | 13.421M 131.60% | 20.782M 54.85% | 32.746M 57.57% | |
| Operating Margin | -83.88% | -138.16% | -57.48% | -50.78% | -20.10% | 4.07% | 10.98% | 21.07% | 26.97% | 35.06% | |
| EPS YoY % growth | N/A -156.25% | N/A -24.37% | -0.46 56.21% | -0.46 0.10% | -0.18 60.44% | 0.05 127.78% | 0.35 591.60% | 0.67 90.86% | 0.97 46.15% | 1.24 27.31% |
All data in CAD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 -5.59% | -0.10 8.18% | -0.11 25.93% | -0.03 69.44% | -0.06 47.83% | -0.03 70.00% |
| Revenue Q2Q % growth | 6.775M 8.91% | 6.986M 8.16% | 7.07M 34.33% | 8.989M 41.36% | 9.292M 37.15% | 9.393M 34.45% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.61M -8.08% | -3.242M 8.62% | N/A | N/A | N/A | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.10 0.87% | -0.10 | 0.00 | -3.32% |
| Q1 2025 Q2Q % growth | -0.15 -7.14% | -0.11 | -0.04 | -35.01% |
| Q4 2024 Q2Q % growth | -0.11 47.62% | -0.12 | 0.01 | 5.29% |
| Q3 2024 Q2Q % growth | -0.11 42.11% | -0.10 | -0.01 | -8.91% |
| Q2 2024 Q2Q % growth | -0.10 66.67% | -0.13 | 0.03 | 23.84% |
| Q1 2024 Q2Q % growth | -0.14 64.60% | -0.21 | 0.07 | 32.38% |
| Q4 2023 Q2Q % growth | -0.21 -196.53% | -0.17 | -0.04 | -22.31% |
| Q3 2023 Q2Q % growth | -0.19 5.00% | -0.23 | 0.04 | 18.21% |
| Q2 2023 Q2Q % growth | -0.30 -15.38% | -0.19 | -0.11 | -56.33% |
| Q4 2022 Q2Q % growth | 0.22 226.70% | % | ||
| Q3 2022 Q2Q % growth | -0.20 -150.00% | -0.16 | -0.04 | -23.76% |
| Q2 2022 Q2Q % growth | -0.26 -766.67% | -0.17 | -0.09 | -51.43% |
| Q4 2021 Q2Q % growth | -243.40% | -0.17 | % | |
| Q3 2021 Q2Q % growth | -0.08 -166.67% | -0.18 | 0.10 | 54.31% |
| Q2 2021 Q2Q % growth | -0.03 70.00% | -0.15 | 0.12 | 80.58% |
| Q1 2021 Q2Q % growth | -0.10 -100.00% | -0.14 | 0.04 | 30.65% |
| Q4 2020 Q2Q % growth | -0.05 83.33% | -0.02 | -0.03 | -142.72% |
| Q3 2020 Q2Q % growth | -0.03 40.00% | 0.00 | -0.03 | % |
| Q2 2020 Q2Q % growth | -0.10 | 0.00 | -0.10 | % |
| Q1 2020 Q2Q % growth | -0.05 | % | ||
| Q2 2019 Q2Q % growth | -0.10 | -0.05 | -0.05 | -94.17% |
| Q1 2019 Q2Q % growth | -0.05 | -0.10 | 0.05 | 51.46% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 6.359M 3.39% | 6.503M | -144.262K | -2.22% |
| Q1 2025 Q2Q % growth | 5.263M -7.47% | 6.818M | -1.555M | -22.81% |
| Q4 2024 Q2Q % growth | 6.459M 15.34% | 6.595M | -136K | -2.06% |
| Q3 2024 Q2Q % growth | 6.221M 20.31% | 6.129M | 92K | 1.50% |
| Q2 2024 Q2Q % growth | 6.15M 18.63% | 5.911M | 239K | 4.04% |
| Q1 2024 Q2Q % growth | 5.688M 21.31% | 5.404M | 284K | 5.26% |
| Q4 2023 Q2Q % growth | 5.6M 6.89% | 5.763M | -163K | -2.83% |
| Q3 2023 Q2Q % growth | 5.171M 7.39% | 5.488M | -317K | -5.78% |
| Q2 2023 Q2Q % growth | 5.184M 9.78% | 5.315M | -131K | -2.46% |
| Q1 2023 Q2Q % growth | 4.689M 2.20% | % | ||
| Q4 2022 Q2Q % growth | 5.239M 7.43% | % | ||
| Q3 2022 Q2Q % growth | 4.815M 6.62% | 5.353M | -538K | -10.05% |
| Q2 2022 Q2Q % growth | 4.722M -0.69% | 5.05M | -328K | -6.50% |
| Q1 2022 Q2Q % growth | 4.588M 21.86% | % | ||
| Q4 2021 Q2Q % growth | 4.877M 17.65% | 5.05M | -173.5K | -3.44% |
| Q3 2021 Q2Q % growth | 4.516M 11.94% | 6.114M | -1.598M | -26.14% |
| Q2 2021 Q2Q % growth | 4.755M 50.35% | 6.09M | -1.335M | -21.93% |
| Q1 2021 Q2Q % growth | 3.765M 38.62% | 5.974M | -2.209M | -36.98% |
| Q4 2020 Q2Q % growth | 4.145M 56.94% | 4.886M | -741.32K | -15.17% |
| Q3 2020 Q2Q % growth | 4.034M 49.67% | 4.616M | -582.06K | -12.61% |
| Q2 2020 Q2Q % growth | 3.162M 16.40% | 4.216M | -1.053M | -24.99% |
| Q1 2020 Q2Q % growth | 2.716M -5.45% | % | ||
| Q4 2019 Q2Q % growth | 2.641M | 3.209M | -568.329K | -17.71% |
| Q3 2019 Q2Q % growth | 2.696M | 2.757M | -61.139K | -2.22% |
| Q2 2019 Q2Q % growth | 2.717M | 3.502M | -785.2K | -22.42% |
| Q1 2019 Q2Q % growth | 2.873M | 4.738M | -1.865M | -39.37% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -43.75% | 2.15% | -31.88% |
| Revenue | 0% | -10.56% | -2.35% | -2.35% |